Concepedia

Gabriel E. Molina

GE

Statistics

Publications

15

Citations

627

H-Index

15

Active since

2011

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Innovative Research (United States)

University of Florida

Dana-Farber Cancer Institute

Gabriel E. Molina is an author at Massachusetts General Hospital specializing in immunology, immunotherapy, and immune-related adverse events.

ORCID

Publications per year

2011–2025

15

Publications

15

Budesonide treatment for microscopic colitis from immune checkpoint inhibitors

Michael Sang Hughes, Gabriel E. Molina, Steven T. Chen et al. · Journal for ImmunoTherapy of Cancer · 2019 · 98 citations · Full text

, , +14

Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors

Harish Seethapathy, Sophia Zhao, Ian A. Strohbehn et al. · Kidney International Reports · 2020 · 75 citations · Full text

, , +16

Intermediate filaments enable pathogen docking to trigger type 3 effector translocation

Brian C. Russo, Luisa M. Stamm, Matthijs Raaben et al. · Nature Microbiology · 2016 · 61 citations · Full text

, , +16

Patterns of Cutaneous and Noncutaneous Immune-Related Adverse Events Among Patients With Advanced Cancer

Leah L. Thompson, Nira A. Krasnow, Michael S. Chang et al. · JAMA Dermatology · 2021 · 59 citations · Full text

, , +17

Temporal Trends and Outcomes Among Patients Admitted for Immune-Related Adverse Events: A Single-Center Retrospective Cohort Study from 2011 to 2018

Gabriel E. Molina, Leyre Zubiri, Justine V. Cohen et al. · The Oncologist · 2021 · 47 citations · Full text

, , +17

1–5 of 15